🧪 Reproducible IP starts with reliable reagents. Absea® Anti-HA beads (MB-301) — benchmarked vs top brands by IP-WB and IP-MS: • capture comparable • cleaner elutions, less antibody carryover • ~10% higher target:total iBAQ. Connect with us for data & protocols. #Proteomics #IPMS

Absea will be in Toronto for HUPO 2025 (Nov 9–13)! Philip (SVP) and Clément (Assoc. Dir., Proteomics) will be at Booth 204 to connect with peers and share insights on proteomics workflows. If you’re attending, stop by or DM to schedule a chat! #HUPO2025 #Proteomics

Great to be in Vienna for BIO-Europe 2025. Philip (SVP) and Crystal (Sales & Product Spec) from Absea are connecting with peers across biotech to share insights and discuss new collaboration opportunities. If you’re attending and would like to connect, our DMs are open! #BIOEurope

Autoantibodies (p53, SOX2, NY-ESO-1, MAGE) can appear early and persist — the immune system’s first signal of cancer. Absea now provides high-purity human recombinant proteins with batch stability and strict quality control, supporting assay development & validation. Message us: [email protected]

Absea will be in Vienna for #BIOEurope, Nov 3–5. Our SVP and Sales & Product Spec will take part in discussions across the biotech value chain, focusing on collaboration and research impact. If you're attending let's connect! We still have a few 1:1 meeting slots available — DMs open.

🔬 Meet Marco Hennrich, our Senior Scientist at Absea! 🎓PhD from @utrechtuniversity.bsky.social He builds integrated platforms for life sciences ✅ Turning complex biology into reproducible insights From aging stem cells to lipid transport proteins, Marco makes science clear 👏 #Proteomics

🔬 In PROTAC and molecular-glue research, verifying mechanism of action is essential to confirm E3 recruitment. Absea’s Pullroven® IP-MS-validated E3 antibodies deliver mass-spec-grade readouts of E3 enrichment for confident mechanistic validation. #PROTAC #TPD

CNHUPO 2025 is underway in Guangzhou! Our SVP Philip Lössl and Marketing Dir. Joy Zhou are meeting peers, including @fan-liu.bsky.social(Absea SAB), and following inspiring sessions across the proteomics community. Great to see Absea featured in @mannlab.bsky.social. presentation. #teammassspec

New in @natgenet.nature.com: “A standardized framework for circulating blood proteomics” — co-authored by our SVP, Philip Lössl. Recommends pooled plasma refs + isotope-labeled protein spike-ins. Thoughts on adoption? Learn more about👇 #Proteomics #15N #teammassspec

Day 1 at the Westlake Symposium for AI Proteomics & Virtual Cell! Philip Lössl (our SVP) already chaired a panel — excited to connect with peers and discuss AI-driven proteomics. Attending? Reach out, we’d love to chat! #Proteomics #LifeSciences #Ai #teammassspec

Back-to-back proteomics in China. After Westlake (Oct 8–10), Absea is heading to CNHUPO 2025 in Guangzhou (Oct 11–14). Philip Lössl (SVP) & Joy Zhou (Marketing Dir.)will represent our team Looking forward to connecting — DMs open for 1:1s! #CNHUPO2025 #Proteomics #Biotech #Conference

ECDC: ~317,000 chikungunya cases in 2025 (Aug 2025). Absea® Recombinant CHIKV E2 Protein (PQ-4086) is a reliable antigen standard that: • Preserves E2 structure • Supports assay specificity • Speeds IVD development Reach out for samples and technical info! 📩 #chikungunya #biotech #LifeSciences

Heads up, #Proteomics Community! 📢 We're sending our team to the Westlake Symposium for AI Proteomics & Virtual Cell (Oct 8–9). Participants include Tao Chen (CEO), Philip Lössl (SVP), and Joy Zhou (Marketing Dir.). Here to exchange ideas and connect, DM us if you'd like to organise a 1:1!

Summer’s wrapping up! Our team swapped pipettes for plates and slides for stories across two September team days: one exploring Schorfheide, another enjoying an evening picnic. Plenty of catching up, some quick decisions, and now ready for autumn experiments! #Teamwork #AutumnVibes

Testing pan-allelic enrichment in AML PBMCs with Absea MB-081 beads. ✔️ matched competitors for peptide yield and neoantigen IDs ✔️ motifs remained stable ✔️ beads maintained performance after >12 months’ storage. RUO. Contact [email protected] or see datasheets on: www.absea.bio/product-deta...

📢 New paper co-authored by our SAB member Bruce Stillman (cshlnews.bsky.social) in Nature SMB delves into how ORC, Cdc6, Cdt1 & MCM2-7 license DNA replication origins — tying structural and biochemical work to genome-stability implications. Read more here: www.nature.com/articles/s41...

How do you measure “N” in the AT(N) Alzheimer’s framework? t-tau? Too much from peripheral Big-tau. NfL? Not AD-specific. BD-tau offers a more specific blood readout. Absea’s new BD-Tau125 antibody pinpoints the exon 4–5 junction, detecting brain-derived tau with high specificity. Details below 👇

Our CEO, Tao Chen, will present “Synthetic and interaction proteomics for systems aging biology” at the Stem Cell, Aging, and Rejuvenation session — Cold Spring Harbor Asia. 🗓 Tue, Sept 16 — 19:00 CEST Want to follow the session or connect afterward? DM us! #proteomics #aging

MTBR-tau243 — a disease-specific Alzheimer’s biomarker that tracks NFT burden. Unlike some p-tau measures, it rises through disease stages. Absea’s mAbs (ELISA epitope mapping) enable sensitive CSF & plasma detection for staging, monitoring & trials. Connect with us or visit: www.absea.bio !

New in MCP: Absea’s ¹⁵N protein standards supported multi-peptide quantification in patient plasma (ALD panel). LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in). Read more here: www.mcponline.org/article/S153... #Proteomics#MassSpec mannlab.bsky.social

For Tau research, breadth and specificity matter. Absea's antibody toolkit targets >50 site-specific pTau isoforms (not just p-Tau181/217 but rare ones like p-Tau205), all with mapped epitopes and assay validation. A comprehensive resource for reliable results.  Let’s get in touch!

Ever pieced together three kits just to hit five targets? 😓. Now imagine a single kit where you pick: • Five validated #antibodies (10 µL each) • One or two free 100 µL secondary antibodies That’s our brand new Pick 5‑ #AntibodyKit —one kit, no extra orders. Connect with us to get started!

Trouble with IP? Absea’s anti-Myc/HA/FLAG magnetic beads are IP-verified and show strong signal, low background, and stable performance across tags and elution modes. Happy to share protocols or tips—let’s connect! #ProteinResearch #LifeScience

Grateful to everyone who joined our lunch seminar at @asbmb.bsky.social #Proteomics yesterday! Great to connect with you and answer all your questions! Final day today, stop by our booth on the second floor to meet our team and discuss your proteomics challenges. We look forward to seeing you!

Nearly 24 hours to go before our first Lunch Seminar at the @asbmb.bsky.social #Proteomics meeting at @broadinstitute.org Join ‪@savitski-lab.bsky.social as he presents on Chemical Proteomics. 🗓 Wed, Aug 20 | 12:30–2:00 PM 📍 Broad Institute Auditorium Register here: www.absea.bio/asbmb2025.html

Last night, we welcomed members of the proteomics community for a special Absea Night ahead of the @asbmb.bsky.social #Proteomics meeting. Great conversations, shared ideas, and plenty of smiles made it a night to remember! Excited for the conference to officially start today! #TeamMassSpec

✅Proteins folded ✅antibodies cleaned up ✅lunch (seminar*) prepared (signup: rb.gy/unk030, talks by @mannlab.bsky.social & @savitski-lab.bsky.social) Our CEO Tao Chen, SVP Philip Lössl, sen scientist Marco Hennrich, and US director Ting Zhao are ready for the @asbmb.bsky.social #proteomics meeting!

Only 1 day to go till the @asbmb.bsky.social proteomics meeting at @broadinstitute.org 🚨Don’t miss Matthias Mann’s @mannlab.bsky.social plenary talk at the first-ever Absea lunch seminar on Wednesday August 20, 12:30 PM! Secure your spot here: absea.bio/asbmb2025.html #Proteomics #TeamMassSpec

ASBMB's symposium on #proteomics in the life sciences starts on Sunday! What topics are you most excited to learn about? Reply to let us know! ow.ly/8aJ850WGoTr Thank you to our sponsors, including: @biognosys.bsky.social, @abseabio.bsky.social, @evosep.bsky.social & @mobilionsystems.bsky.social!

Not all antibody kits work for everyone. We’re building flexible tools like the Pick 5 Antibody Kit — but we would like your input. What’s your biggest frustration with commercial kits? 🧪 Reply with: • Poor validation • No flexibility • Inconsistency • Bad support • Other?

Absea debuts its first lunch seminar at @asbmb.bsky.social Proteomics Meeting! 🗓️ Wed, Aug 20 | 🕧 12:30–2:00 PM 📍 Broad Institute auditorium Featuring talks from Matthias Mann (Max Planck) & Mikhail Savitski (EMBL) More Information → buff.ly/s5mZJLN Big proteomics ideas and lunch on us!

Excited to share: A Nature Communications study led by Fan Liu (Absea SAB Chair, FMP Berlin) introduces SHVIP—a method revealing 739 virus–host PPIs in intact HSV-1 infected cells. It preserves membrane structure & uses AlphaFold to interpret complex networks. 🔗

Why settle for just one antibody? With our new Pick 5 Antibody Kit, you choose only what you need — no waste, just results. 🧪 Includes up to two free 100 μL secondaries, all at a single price. 💡 Found a match? Reorder and get 20% off. 👇 Check the next image to see how it works!

Publication Spotlight: Advanced imaging reveals KIF13B enrichment at retinal synaptic ribbons! Suiwal et al. (IJMS, Saarland Univ.) use confocal/SR-SIM/EM & a new monoclonal antibody (by Absea) to map KIF13B at the photoreceptor ribbon. 👉 doi.org/10.3390/ijms... #Neuroscience #VisionScience

Ahead of the @asbmb.bsky.social‬ Proteomic Meeting, we’re curious: Which emerging MS proteomics application has proven toughest to turn into routine data in your hands? • Single-cell proteomics • Spatial proteomics • DIA-based PTM profiling • Abs quant prot biomarkers Share your thoughts below!

⏳ Last day to register for asbmb.bsky.social Proteomics, Aug 17–21 (Cambridge)! Meet Absea’s CEO, SVP & scientists (booth, 2nd floor) Dive into mass spec & antibody tech Chat about your proteomics challenges Proud to sponsor and eager to hear what you’re working on! #Proteomics #LifeSciences

🚀 We're heading to Cambridge for the ASBMB Proteomics Meeting, Aug 17–21! Proud sponsor of this year's event by asbmb.bsky.social - Meet our CEO, SVP & scientists - Visit our booth on the second floor - Have a research challenge? Tell us! 👀 Special announcement soon. #LifeSciences #Proteomics

Big news! Absea Biotech’s antibody collection on Europa Biosite is now 13,714 strong(up from 7,726)! 🎉 More recombinant antibodies, lyophilized shipments, and fresh data sheets to boost your research. Explore what’s new here 👇 #Proteomic #Research #Antibodies

Autophagy research is complex. Finding reliable antibodies shouldn’t be. We provide rigorously validated monoclonal antibodies covering key autophagy proteins—designed to support your experiments with proven reliability. Happy to share insights or answer questions! #Autophagy #Biotech

In case you missed it: DQGlyco, led by Mikhail @savitski-lab.bsky.social (@embl.org, Absea SAB) & Clément M. Potel (then @embl.org, now Absea), enables deep profiling of 177,000+ N-glycopeptides in mouse brain (25× more than before). New insights into protein & microbiome interplay. #Proteomics

Innate immunity relies on rapid, precise detection of pathogens & danger signals. Absea’s validated antibodies cover TLRs, RIG-I, MDA5, NLRP3, cGAS-STING & more—reliable for WB, IP, IHC in infection, cancer & aging research. Which innate pathway are you working on? Let’s connect! #Immunology

☀️ Celebrating our first official summer after works! Working together is part of our daily routine, but we couldn’t resist stepping out of the lab to enjoy the first “hints” of summer. Catching up and recharging together fuels our innovation in protein engineering and proteomics!

🧠 Still chasing reproducibility in neurobiology—especially with tricky proteins like Tau or β-amyloid. We’re always refining our monoclonal antibodies to help researchers get clearer results. What’s your best tip for reliable biomarker data? #Neuroscience #Biomarkers

What does it take to expand access to the human proteome? Today we explore how we’ve produced 14,000+ proteins to date, now supporting new directions in disease biology and biomarker research. Check out our thread for details and let’s connect! #Proteomics #Biotech

🧠 June is Brain & Alzheimer’s Awareness Month. We are committed to supporting researchers with our trusted antibodies for Aβ40, Aβ42, and alpha-synuclein—enabling sensitive biomarker detection in Alzheimer’s and Parkinson’s studies! 👀Tau solutions coming soon. #BrainAwarenessMonth #Neuroscience

❓ Which mass-spec application is most critical in your lab? 🔹 Protein interaction mapping? 🔹 Quantitative proteomics? 🔹 Biomarker discovery? 🔹 Structural proteomics? Reply with your focus in the comments! #MassSpec #Proteomics

🧬 Tumor immune evasion: ↓ MHC I (up to 60%) PD-L1/CTLA-4 TGF-β/Tregs/MDSCs Warburg/IDO1 ⚠️ Only 20–30% of patients respond long-term to ICIs. 🔬 Absea antibodies target these escape routes. ➡️ Which mechanism are you tackling? Learn more: www.absea.bio #TumorImmunity #CancerResearch #Immunotherapy

That’s a wrap on #ASMS2025! 🙌 Thanks to everyone who visited Absea’s booth—your questions and ideas made it a great week. Top 3 discussed tools: 15N-labeled proteins, MHC-targeting antibodies, IHC-validated antibodies. Exciting 15N news on the horizon—stay tuned! 👀 #Proteomics #MassSpec

🚨 Final poster session at #ASMS2025 —your last chance to connect with Absea at Booth 821! Discover high-throughput proteomics and validated antibodies, covering 70% of the human proteome for comprehensive discovery. 🎉 Prize winner revealed at noon—stay tuned! #MassSpec

Halfway through #ASMS2025! Curious how our N-15 proteins or MHC solutions can fit your proteomics projects? Visit Booth #821 to chat with our team, learn about our reagent tools, and join our 5-year anniversary prize draw. We look forward seeing you here!! 🧬🎉 #Biotech #Lifesciences